|
TTRX Turn Therapeutics Inc 2023016 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-5,849,734.00 |
| Balance Sheet |
|
Current Assets
|
$10,428,198.00 |
|
Assets
|
$16,960,719.00 |
|
Current Liabilities
|
$8,764,111.00 |
|
Liabilities
|
$16,273,831.00 |
|
Equity
|
$686,888.00 |
|
Shares Out
|
29788040.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,556,171.00 |
|
Investing Cash Flow
|
$-18,025.00 |
| Market Analysis |
Market Cap
|
$284,177,901.60 |
|
Price
|
$9.54 |
|
BVPS
|
0.02 |
|
PB
|
477.00 |
|
EPS
|
-0.20 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:48 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:38 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-0.12 |
|
|
2026-05-11 |
-0.03 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TTRX documents filed with the SEC.
TTRX Filings
Clear
